Reach Us +1-504-608-2390
Editor - Haval Shirwan | University of Louisville | 1557
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Haval Shirwan

Haval Shirwan
Executive Editor
Haval Shirwan

Department of Microbiology and Immunology
University of Louisville
Tel: 502-852-2066
Fax: 502-852-2085
University of Louisville


Dr Shirwan is Dr Michael and Joan Hamilton Endowed Chair in Autoimmune Disease Professor of Microbiology and Immunology and the Director of the Molecular Immunomodulation Program at the Institute for Cellular Therapeutics. He conducted his graduate studies at the University of California in Santa Barbara CA and postdoctoral studies at California Institute of Technology in Pasadena CA. He joined the University of Louisville in 1998 after holding academic appointments at various institutions in the United States. Dr Shirwans research focuses on the modulation of immune system for the treatment of immunebased diseases with particular focus on type 1 diabetes transplantation and development of vaccines against infections and cancer. Dr Shirwan is widely published lectured at various national/international conferences served on various federal and nonprofit funding agencies and is on the Editorial Board of nine scientific journals He is a member of several national and international societies and recipient of various awards.

Research Interest

Transplantation Tolerance, Transplantation Immunology, Type 1 diabetes, Prophylactic Vaccines, Therapeutic Vaccines, Cancer Immunology



Global Speakers in the subject

Global Experts in the subject


The Promise of PD-1 Signaling Pathway for Cancer Immunotherapy

Rajesh Kumar Sharma, Esma S. Yolcu and Haval Shirwan
Editorial: J Clin Cell Immunol 2012, 3: e110
DOI: 10.4172/2155-9899.1000e110